By Nakul Iyer
(Reuters) - Gold slipped on Monday and was on track for its worst month in four years, as optimism over a coronavirus vaccine-led economic rebound that propelled equities to record highs dulled the metal's safe-haven appeal.
Spot gold fell 1.2% to $1,766.26 per ounce by 0301 GMT. Gold is down 5.9% so far this month, its biggest monthly decline since November 2016.
U.S. gold futures dropped 0.5% to $1,772.60.
"Vaccine inspired optimism about an economic bounce is really eroding the attraction of safe-haven investments like gold... the breach of $1,800 is feeding into the market imagination and appears to be another trigger," said Michael McCarthy, chief strategist at CMC Markets.
Vaccine optimism drove the dollar to a more than two-year low and put world stocks on course for a record month of gains.
Also bolstering risk sentiment was data that showed China's factory activity expanded at the fastest pace in more than three years in November.
Investors now eye testimony Congressional by U.S. Federal Reserve Chairman Jerome Powell this week, for clues on the likely direction monetary policy might take.
"The risks are that the Fed will slow down or even halt its bond purchasing program and that's another reason to be cautious about the outlook for gold," McCarthy added.
Gold is seen as a hedge against inflation likely to result from monetary stimulus.
Wall street bank Citi expects bullion's sell-off to taper in December with support in the mid $1700s.
"A renewed push above $2,000/oz in the next 3-6 months seems likely," the bank added in a note, citing its bearish dollar outlook and low-interest rates as tailwinds.
Lower interest rates reduce the opportunity cost of holding non-yielding bullion.
Silver slipped 3.2% to $21.96 per ounce, while platinum fell 0.9% to $954.64 and palladium was down 0.4% at $2,416.22.
(Reporting by Nakul Iyer in Bengaluru; Editing by Rashmi Aich)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)